Cargando…
Case Report: sintilimab-induced Stevens-Johnson Syndrome in a patient with advanced lung adenocarcinoma
Immune checkpoint inhibitors (ICIs) have been widely applicated in clinical therapy in recent years. Skin-related adverse reaction is one of the most common adverse events for ICIs. Stevens-Johnson syndrome (SJS) is one of the serious cutaneous reactions threatening the life. Here, we reported a cas...
Autores principales: | Li, Xueqin, Li, Guanghui, Chen, Diangang, Su, Linxi, Wang, Ru-peng, Zhou, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540079/ https://www.ncbi.nlm.nih.gov/pubmed/37781182 http://dx.doi.org/10.3389/fonc.2023.912168 |
Ejemplares similares
-
Case report: Alpelisib-induced Stevens–Johnson syndrome
por: Kurian, Christine Jane, et al.
Publicado: (2022) -
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review
por: Deng, Min, et al.
Publicado: (2021) -
Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report
por: Jiang, Ziyu, et al.
Publicado: (2023) -
Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019)